April 18, 2026·3 min read·methodology, research
The four-phase research cycle
How to run a peptide protocol like an engineer — define the endpoint, measure the baseline, run the cycle, review the data.
How to run a peptide protocol like an engineer — define the endpoint, measure the baseline, run the cycle, review the data.
Most peptide work fails for the same reason most nutrition advice fails: the user doesn't define what success looks like before starting. Without an endpoint, you can't tell whether a compound worked, whether the dose was right, or whether the variable that changed your outcome was the peptide or the fact that you started sleeping seven hours instead of five.
NeuroForge's approach borrows from basic experimental design. Four phases, run in order, for every cycle.
Pick one. Not three. Body composition, VO₂ max, Oura recovery score, fasting insulin, pull-up max, resting heart rate variability — whatever maps to the reason you're running the compound. Write it down. If you can't measure it weekly with something you already own, pick a different endpoint. A GHK-Cu protocol might target skin collagen density; a MOTS-c cycle might track fasting glucose; an Epithalon stack might monitor sleep architecture.
Measure for at least two weeks before starting. One data point is a coincidence. A line is a trend. The baseline phase is also where you stabilize the non-peptide variables: sleep, caloric intake, training load. If those are moving around, a new compound won't tell you anything.
Every compound has a half-life, a dose-response curve, and a literature-based cycle length. Run the protocol for the full cycle — typically 4 to 12 weeks depending on the peptide class. Don't stack two new compounds simultaneously; if both are new to you, the signal is unattributable. TB-500 healing protocols typically run 6-8 weeks; Selank anxiolytic work runs 4-12 weeks; Epithalon longevity stacks use intermittent cycling (weeks on, months off).
Compare your weekly endpoint data against the baseline. Three questions:
If the answer to (1) is yes and (3) is no, you have signal. Document it. Next cycle, you can extend the protocol, adjust the dose, or stack a second compound with confidence — because the first one has a known baseline effect in your physiology.